| scholarly article | Q13442814 |
| P2093 | author name string | Raanan Margalit | |
| Zecharia Madar | |||
| Oren Tirosh | |||
| Sarit Anavi | |||
| Michal Hahn-Obercyger | |||
| P2860 | cites work | Sepsis-induced increases in glucose uptake by macrophage-rich tissues persist during hypoglycemia | Q48717640 |
| The isolated hepatocyte preparation: 30 years on. | Q51556280 | ||
| Hypoglycemia in sepsis: Biomarker, mediator, or both?* | Q61362158 | ||
| Give me iNOS or give me death | Q74300407 | ||
| Inducible nitric oxide synthase in the liver: regulation and function | Q77165703 | ||
| Glucose release as a response to glucagon in rat hepatocyte culture: involvement of NO signaling | Q80810562 | ||
| Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice | Q82482777 | ||
| Effect of nitric oxide on the hypoglycaemic phase of endotoxaemia | Q83974644 | ||
| Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver | Q24647278 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance | Q28578312 | ||
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis | Q29619888 | ||
| The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock | Q33282754 | ||
| Hypoglycemia and outcome in critically ill patients | Q33744183 | ||
| A Soluble Guanylate Cyclase–Dependent Mechanism Is Involved in the Regulation of Net Hepatic Glucose Uptake by Nitric Oxide in Vivo | Q34355140 | ||
| Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs | Q34360096 | ||
| Is nitric oxide overproduction the target of choice for the management of septic shock? | Q34463493 | ||
| Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. | Q35266454 | ||
| Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. | Q36163946 | ||
| Steatosis: co-factor in other liver diseases. | Q36165987 | ||
| Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet | Q36345103 | ||
| Steatosis as a risk factor in liver surgery | Q36696488 | ||
| HIF-1-regulated glucose metabolism: a key to apoptosis resistance? | Q36778658 | ||
| Nitric oxide in shock | Q36835542 | ||
| Severe hypoglycemia in critically ill patients: risk factors and outcomes | Q36918620 | ||
| HIF-1 in the inflammatory microenvironment | Q37426830 | ||
| Animal models of non-alcoholic steatohepatitis: of mice and man. | Q37749366 | ||
| Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk | Q37769024 | ||
| Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease | Q37825687 | ||
| Nitric oxide signaling in hypoxia | Q37986339 | ||
| Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis | Q38310080 | ||
| IRE1-dependent activation of AMPK in response to nitric oxide | Q38960360 | ||
| Nitric oxide inhibits glycogen synthesis in isolated rat hepatocytes | Q42096163 | ||
| The role of the gut microbiota in nonalcoholic fatty liver disease | Q42838234 | ||
| Infusion of a lipid emulsion modulates AMPK and related proteins in rat liver, muscle, and adipose tissues | Q43199689 | ||
| Impaired liver glucose production in a murine model of steatosis and endotoxemia: protection by inducible nitric oxide synthase | Q43232968 | ||
| HIF-1alpha is necessary to support gluconeogenesis during liver regeneration. | Q45915873 | ||
| Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. | Q45961515 | ||
| The control of hepatic glycogen metabolism in an in vitro model of sepsis | Q46952674 | ||
| P433 | issue | 16 | |
| P921 | main subject | endotoxemia | Q5832599 |
| P304 | page(s) | 1889-1901 | |
| P577 | publication date | 2013-07-24 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia | |
| P478 | volume | 19 |
| Q90706295 | Cholesterol Prevents Hypoxia-Induced Hypoglycemia by Regulation of a Metabolic Ketogenic Shift |
| Q36860986 | Does Citrulline Have Protective Effects on Liver Injury in Septic Rats? |
| Q55425011 | Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. |
| Q26797323 | Image-Guided Hydrodynamic Gene Delivery: Current Status and Future Directions |
| Q28078586 | Liver-targeted hydrodynamic gene therapy: Recent advances in the technique |
| Q40039939 | Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases |
| Q38861311 | The role of iNOS in cholesterol-induced liver fibrosis |
| Q51730568 | Translational Advances of Hydrofection by Hydrodynamic Injection. |
Search more.